Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 3 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Caps

How do you think BRLI will perform against the market?

Add Stock to CAPS Watchlist

All Players

268 Outperform
19 Underperform
 

All-Star Players

58 Outperform
2 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top BRLI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

debster863 (< 20)
Submitted March 04, 2011

I work in Healthcare, this lab has just come into our organization, we currently use labcorp and quest. I started researching bio-referance and it seems a strong company. lots of positives (growth, gendx, cancer research etc). still researching but… More

ac11166 (< 20)
Submitted August 29, 2006

May be trading at an acquisition premium today. Premium to peers is definitely not supported by historical growth rate or risks inherent in "price taker" position with Medicare and Medicaid.

BRLI VS S&P 500 (SPY)

Fools bullish on BRLI are also bullish on:

Fools bearish on BRLI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BRLI.

Recs

0
Member Avatar MWillou (29.57) Submitted: 12/20/2013 9:30:14 AM : Outperform Start Price: $25.20 BRLI Score: -10.17

Near-term ACA pressure will negatively impact BRLI and the other healthcare provider (health system, clinical labs) companies. Several years out, I expect BRLI to increase because it performs esoteric tests that DGX and LH do not. Game changer in lab industry is Theranos, who is not doing esoteric testing right now.

Recs

0
Member Avatar tecramer (< 20) Submitted: 9/2/2013 8:33:18 PM : Outperform Start Price: $29.29 BRLI Score: -43.13

This small player has lots of room to grow with some innovative tests and interesting acquisitions that should help expand market share along with geographic coverage.

Recs

0
Member Avatar cheezyches (97.31) Submitted: 4/16/2013 8:19:16 AM : Outperform Start Price: $23.76 BRLI Score: -24.86

BRLI is operating in a long-term trend of increasing health care. It's financial results have shown robust growth trajectories over the last few years. I do not see any reason for this trend to change.

Leaderboard

Find the members with the highest scoring picks in BRLI.

Score Leader

avscaptain

avscaptain (88.24) Score: +134.56

The Score Leader is the player with the highest score across all their picks in BRLI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
kd554 < 20 8/28/2006 Outperform 1Y $10.46 +230.88% +119.11% +111.77 0 Comment
dsks68 < 20 8/28/2006 Outperform 3Y $10.46 +230.88% +119.11% +111.77 1 Comment
tomkat104 28.01 8/29/2006 Outperform 5Y $10.53 +228.68% +118.79% +109.89 0 Comment
bigreenmountain 91.47 1/23/2007 Outperform 3Y $11.22 +208.60% +98.84% +109.76 0 Comment
PapaMan200 95.99 8/29/2006 9/7/2006 Outperform 5Y $10.53 +228.68% +119.28% +109.40 0 Comment
NetscribeHealthC 66.04 1/31/2007 Outperform 1Y $11.39 +203.86% +98.33% +105.53 1 Comment
dfox20 49.26 10/6/2006 Outperform 3Y $10.97 +215.64% +110.43% +105.21 0 Comment
boyet7 97.04 10/4/2006 Outperform 1Y $10.90 +217.67% +112.73% +104.94 1 Comment
mjl75 < 20 1/8/2007 Outperform 5Y $11.33 +205.61% +100.91% +104.70 0 Comment
djkellyoz < 20 1/5/2007 Outperform 1Y $11.37 +204.40% +100.15% +104.25 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.08 11/1/2012 Outperform 3W $28.13 +23.04% +86.59% -63.56 0 Comment
TrackBofASec 94.85 6/12/2012 Outperform NS $22.88 +28.50% +24.98% +3.52 6/17/2013 @ $29.40 0 Comment
TrackUBS 91.85 7/8/2010 Outperform NS $20.99 +64.89% +150.67% -85.78 0 Comment
TrackTheBenchmar 80.23 6/17/2010 Outperform NS $23.44 +47.65% +137.36% -89.71 0 Comment
TrackOppenheimer 58.02 5/29/2008 Outperform NS $12.67 -3.63% -35.19% +31.56 1/9/2009 @ $12.21 0 Comment
TrackWMBlair 77.93 2/21/2008 Outperform NS $14.46 +139.39% +104.25% +35.14 0 Comment
TrackJefferies 82.31 1/16/2007 Outperform NS $11.87 +23.46% -33.35% +56.82 6/5/2009 @ $14.66 0 Comment
TrackJimCramer 85.08 12/20/2006 Underperform 3W $11.49 +144.82% +0.53% -144.30 11/1/2012 @ $28.13 0 Comment

Featured Broker Partners